SCHEMBL4523137

SCHEMBL4523137

CC(=O)N[C@@H](Cc1cnc2ccccc2n1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
HIF1A Q16665 1/20 0.52
GRN P28799 1/20 0.52
SORT1 Q99523 1/20 0.52
KDM4E B2RXH2 1/20 0.48
HSP90AA1 P07900 1/20 0.48
HSP90AB1 P08238 1/20 0.48
PDE10A Q9Y233 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
PIN1 Q13526 1/20 0.43
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
STAT1 P42224 1/20 0.42
RAB9A P51151 1/20 0.42
PPARG P37231 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4526253 0.85 CYP1A2 (0.67) CYP1A2CYP2C9HIF1AGRNSORT1
SCHEMBL4534450 0.83 PTPN1 (0.54) CYP1A2CYP2C9HIF1AGRNSORT1
SCHEMBL14265381 0.83 PTPN1 (0.54) CYP1A2CYP2C9HIF1AGRNSORT1
SCHEMBL2301880 0.82 CYP1A2 (0.50) CYP1A2KDM4ENPSR1RXFP1PIN1
SCHEMBL4522024 0.79 GRN (0.43) CYP1A2CYP2C9HIF1AGRNSORT1
SCHEMBL7037005 0.79 ACACB (0.53) GRNSORT1PIN1PPARGACACB
SCHEMBL7037002 0.79 ACACB (0.53) GRNSORT1PIN1PPARGACACB
SCHEMBL7897139 0.77 PTPRA (0.58) CYP1A2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL29166033 0.77 PTPRA (0.58) CYP1A2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL23782003 0.76 CYP1A2 (0.55) CYP1A2CYP2C9HIF1AGRNSORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080263-A1 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds CHIRACON GMBH (DE) 2005-04-14 US claimed
US-7626022-B2 Racemic mixtures; oxidation; cyclization; crystallization CHIRACON GMBH (DE) 2009-12-01 US disclosed
US-20050080263-A1 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds CHIRACON GMBH (DE) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080263-A1 Method for producing ss-heteroaryl-alpha-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds AAAS, ASNS, AADAT CYP1A2 95/4885CYP2C9 120/4885HIF1A 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.